Mirna.7z Guide

miR-7 is preferentially expressed in neuroendocrine tissues, specifically the and pancreas .

: It generally acts as a tumor suppressor . Its downregulation is linked to increased proliferation and metastasis in glioblastoma, lung, breast, and colorectal cancers by failing to inhibit oncogenic pathways like EGFR/PI3K/Akt .

The dysregulation of miR-7 is a hallmark of several major pathologies: Mirna.7z

: Recent studies highlight its role in regulating immune responses, including T-cell activation and neuroinflammation. Clinical Potential Due to its broad regulatory reach, miR-7 is a target for:

: Its levels are controlled post-transcriptionally by "sponges" like circular RNA ciRS-7 (also known as CDR1as), which contains over 70 binding sites for miR-7 and can effectively quench its activity. Role in Pathophysiology The dysregulation of miR-7 is a hallmark of

: It regulates the development of the pituitary gland, optic nervous system, and cerebral cortex by targeting factors like PAX6 , which is essential for eye and brain organogenesis.

MicroRNA-7 is a highly conserved, non-coding RNA molecule approximately 22 nucleotides long. In humans, the mature miR-7 sequence is generated from three distinct genomic loci: (Chromosome 9), MIR7-2 (Chromosome 15), and MIR7-3 (Chromosome 19). It is primarily recognized as a "network stabilizer" that maintains cellular homeostasis under environmental stress. Biological Functions and Regulation MicroRNA-7 is a highly conserved, non-coding RNA molecule

: Restoring miR-7 levels through "mimics" is being explored as an adjuvant therapy to sensitize cancer cells to chemotherapy and overcome multidrug resistance.